InnovationMay 26, 2026Making label-free biosensing more accessible to every labLaboratories increasingly rely on label-free technologies to study biomolecular interactions, but high costs, complexity, and limited throughput still restrict widespread adoption.
InnovationMay 26, 2026Making label-free biosensing more accessible to every labLaboratories increasingly rely on label-free technologies to study biomolecular interactions, but high costs, complexity, and limited throughput still restrict widespread adoption.
InnovationMay 26, 2026Making label-free biosensing more accessible to every labLaboratories increasingly rely on label-free technologies to study biomolecular interactions, but high costs, complexity, and limited throughput still restrict widespread adoption.
InnovationConfo Therapeutics Announces Phase 2 Clinical Trial Initiation by Lilly for Peripheral Pain Candidate
InnovationConfo Therapeutics Announces Phase 2 Clinical Trial Initiation by Lilly for Peripheral Pain Candidate
InnovationConfo Therapeutics Announces Phase 2 Clinical Trial Initiation by Lilly for Peripheral Pain Candidate
InnovationKhondrion Announces First Patient Dosed in Pivotal Phase 3 KHENERFIN Study of Sonlicromanol in Mitochondrial DNA 3243A>G Primary Mitochondrial Disease
InnovationKhondrion Announces First Patient Dosed in Pivotal Phase 3 KHENERFIN Study of Sonlicromanol in Mitochondrial DNA 3243A>G Primary Mitochondrial Disease
InnovationKhondrion Announces First Patient Dosed in Pivotal Phase 3 KHENERFIN Study of Sonlicromanol in Mitochondrial DNA 3243A>G Primary Mitochondrial Disease
InnovationUMC Utrecht Researcher Tim Sakkers Wins the I4H Young Innovator Award 2026 with ReveltaDx: Transforming Heart Disease Diagnosis in Women
InnovationUMC Utrecht Researcher Tim Sakkers Wins the I4H Young Innovator Award 2026 with ReveltaDx: Transforming Heart Disease Diagnosis in Women
InnovationUMC Utrecht Researcher Tim Sakkers Wins the I4H Young Innovator Award 2026 with ReveltaDx: Transforming Heart Disease Diagnosis in Women
InnovationOncode Institute and Ligase BioPartners scale proven oncology investment model with launch of Oncology Bridge Fund II
InnovationOncode Institute and Ligase BioPartners scale proven oncology investment model with launch of Oncology Bridge Fund II
InnovationOncode Institute and Ligase BioPartners scale proven oncology investment model with launch of Oncology Bridge Fund II
CareerWerken bij MSD in Nederland: waar wetenschap en wereldwijde impact op het gebied van gezondheid samenkomen
CareerWerken bij MSD in Nederland: waar wetenschap en wereldwijde impact op het gebied van gezondheid samenkomen
CareerWerken bij MSD in Nederland: waar wetenschap en wereldwijde impact op het gebied van gezondheid samenkomen
